Discovery of antitoxins and development of antibody preparations for clinical uses from 1890 to 1990
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Molecular Immunology
- Vol. 28 (12) , 1321-1332
- https://doi.org/10.1016/0161-5890(91)90034-h
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Pseudomonas aeruginosa outer membrane protein F produced inEscherichia coli retains vaccine efficacyCurrent Microbiology, 1990
- S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous ApplicationVox Sanguinis, 1983
- S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous ApplicationVox Sanguinis, 1983
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Preparation of a Stable Intravenous Gamma‐Globulin: Process Design and Scale‐UpVox Sanguinis, 1980
- Hypotension Associated with Prekallikrein Activator (Hageman-Factor Fragments) in Plasma Protein FractionNew England Journal of Medicine, 1978
- THE USE OF SPECIFIC "LYMPHOCYTE" ANTISERA TO INHIBIT HYPERSENSITIVE REACTIONS OF THE "DELAYED" TYPEThe Journal of Experimental Medicine, 1961
- INVESTIGATIONS OF THE USE OF BETA‐PROPIOLACTONE IN VIRUS INACTIVATION*Annals of the New York Academy of Sciences, 1960
- CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES 12Journal of Clinical Investigation, 1944
- ON HEAT-SENSITIVE ANTICOMPLEMENTARY BODIES IN HUMAN BLOOD SERUMThe Journal of Experimental Medicine, 1911